JP2007538054A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007538054A5 JP2007538054A5 JP2007517257A JP2007517257A JP2007538054A5 JP 2007538054 A5 JP2007538054 A5 JP 2007538054A5 JP 2007517257 A JP2007517257 A JP 2007517257A JP 2007517257 A JP2007517257 A JP 2007517257A JP 2007538054 A5 JP2007538054 A5 JP 2007538054A5
- Authority
- JP
- Japan
- Prior art keywords
- substituents
- substituted
- alkoxy
- alkyl
- trifluoromethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57223604P | 2004-05-19 | 2004-05-19 | |
| EP04102210 | 2004-05-19 | ||
| PCT/EP2005/052281 WO2005110413A2 (en) | 2004-05-19 | 2005-05-18 | Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007538054A JP2007538054A (ja) | 2007-12-27 |
| JP2007538054A5 true JP2007538054A5 (https=) | 2008-04-10 |
Family
ID=34969508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007517257A Pending JP2007538054A (ja) | 2004-05-19 | 2005-05-18 | 肥満および関係する病気の予防または治療のためのｎ−スルファモイル−ｎ′−アリールピペラジンを含有する薬剤 |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1750712A2 (https=) |
| JP (1) | JP2007538054A (https=) |
| CN (1) | CN1997370B (https=) |
| AU (1) | AU2005244450B2 (https=) |
| BR (1) | BRPI0510137A (https=) |
| CA (1) | CA2567166A1 (https=) |
| IL (1) | IL178903A0 (https=) |
| MX (1) | MXPA06013299A (https=) |
| NO (1) | NO20065835L (https=) |
| RU (1) | RU2395503C2 (https=) |
| WO (1) | WO2005110413A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1866298A2 (en) | 2005-03-31 | 2007-12-19 | Takeda San Diego, Inc. | Hydroxysteroid dehydrogenase inhibitors |
| CA2637449A1 (en) * | 2006-01-23 | 2007-07-26 | F. Hoffmann-La Roche Ag | Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| JP5301465B2 (ja) | 2007-01-25 | 2013-09-25 | バーバ・ファーマシューティカルズ・リミテッド | インスリン抵抗性改善薬および治療方法 |
| RU2539591C2 (ru) * | 2009-04-22 | 2015-01-20 | Аксикин Фармасьютикалз, Инк. | Антагонисты арилсульфонамида ccr3 |
| RU2445963C2 (ru) * | 2010-07-09 | 2012-03-27 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая противодиабетическая композиция |
| ES2753386T3 (es) | 2013-03-13 | 2020-04-08 | Forma Therapeutics Inc | Derivados de 2-hidroxi-1-{4-[(4-fenil)fenil]carbonil}piperazin-1-il}etano-1-ona y compuestos relacionados como inhibidores de sintasa de ácido graso (FASN) para el tratamiento del cáncer |
| GB201410817D0 (en) | 2014-06-17 | 2014-07-30 | Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R & D | Therapeutic agents |
| TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
| US10793554B2 (en) | 2018-10-29 | 2020-10-06 | Forma Therapeutics, Inc. | Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2748125A (en) * | 1954-04-26 | 1956-05-29 | American Cyanamid Co | 1-substituted-4-sulfamylpiperazine and method of preparing the same |
| FR2030116A1 (en) | 1969-01-02 | 1970-10-30 | Sandoz Sa | Herbicide compositions and prepn |
| US3709677A (en) * | 1969-06-25 | 1973-01-09 | Sandoz Ag | N-substituted sulfamoyl compounds useful as herbicides |
| SU1646258A3 (ru) * | 1989-02-08 | 1996-02-10 | Институт биохимии Литовской АН | 5-аминонафталин-1-сульфамиды в качестве детектируемых групп субстратов для флюоресцентного анализа пептидаз |
| DE4025387A1 (de) | 1990-08-10 | 1992-02-13 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als reagenzien |
| US5728704A (en) * | 1992-09-28 | 1998-03-17 | Pfizer Inc. | Substituted pyridmidines for control of diabetic complications |
| AU7782694A (en) * | 1993-09-28 | 1995-04-18 | Ciba-Geigy Ag | Acylated sulphonamides as insecticides and acaricides |
| PL334846A1 (en) * | 1997-01-23 | 2000-03-27 | Hoffmann La Roche | Sulphamidic inhibitors of metaloproteases |
| DE10035227A1 (de) | 2000-07-20 | 2002-01-31 | Solvay Pharm Gmbh | Verfahren zum Auffinden von Verbindungen, welche zur Behandlung und/oder Prophylaxe von Fettleibigkeit geeignet sind |
| MXPA04008797A (es) * | 2002-03-13 | 2004-11-26 | Janssen Pharmaceutica Nv | Inhibidores de histona desacetilasa. |
| DE60325051D1 (de) * | 2002-06-06 | 2009-01-15 | Boehringer Ingelheim Pharma | SUBSTITUIERTE 3-AMINO-THIENO(2,3-b)PYRIDINE-2-AMIDE UND HERSTELLUNGSVERFAHREN SOWIE DEREN VERWENDUNG |
| WO2005005382A2 (en) * | 2003-07-02 | 2005-01-20 | Cytokinetics, Inc. | Compounds, compositions and methods |
| EP2311827A1 (en) | 2004-08-28 | 2011-04-20 | AstraZeneca AB | Thiopyrimidine derivative, useful as an intermediate for chemokine receptor modulators. |
-
2005
- 2005-05-18 CN CN2005800159695A patent/CN1997370B/zh not_active Expired - Fee Related
- 2005-05-18 BR BRPI0510137-9A patent/BRPI0510137A/pt not_active IP Right Cessation
- 2005-05-18 EP EP05749492A patent/EP1750712A2/en not_active Withdrawn
- 2005-05-18 AU AU2005244450A patent/AU2005244450B2/en not_active Ceased
- 2005-05-18 CA CA002567166A patent/CA2567166A1/en not_active Abandoned
- 2005-05-18 WO PCT/EP2005/052281 patent/WO2005110413A2/en not_active Ceased
- 2005-05-18 RU RU2006144812/04A patent/RU2395503C2/ru not_active IP Right Cessation
- 2005-05-18 JP JP2007517257A patent/JP2007538054A/ja active Pending
- 2005-05-18 MX MXPA06013299A patent/MXPA06013299A/es not_active Application Discontinuation
-
2006
- 2006-10-26 IL IL178903A patent/IL178903A0/en unknown
- 2006-12-18 NO NO20065835A patent/NO20065835L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3423443B1 (en) | Cyano-substituted indole compounds and uses thereof as lsd1 inhibitors | |
| Song et al. | Design and synthesis of novel 2-(indol-5-yl) thiazole derivatives as xanthine oxidase inhibitors | |
| ES2532210T3 (es) | Métodos para el tratamiento concomitante de teofilina y febuxostat | |
| CN110831927B (zh) | 苯基-2-羟基-乙酰氨基-2-甲基-苯基化合物 | |
| EA022301B1 (ru) | Полиморфные формы 2-(5-бром-4-(4-циклопропилнафталин-1-ил)-4h-1,2,4-триазол-3-илтио)уксусной кислоты и их применение | |
| EA024984B1 (ru) | Производные 6-циклоалкил-1,5-дигидропиразоло[3,4-d]пиримидин-4-она и их применение в качестве ингибиторов pde9a | |
| EP2878594B1 (en) | Difluoromethylene compound | |
| ES2802977T3 (es) | Compuesto para la modulación inmunológica, uso del mismo y composición farmacéutica que lo comprende | |
| WO2018234978A1 (en) | Substituted 5-cyanoindole compounds and uses thereof | |
| RU2512547C2 (ru) | Содержащее конденсированную кольцевую структуру производное и его применение в медицине | |
| JP2007538054A5 (https=) | ||
| KR20140129164A (ko) | 히스톤 데아세틸라아제 억제제 및 파조파닙의 조합물 및 이의 용도 | |
| TW200927127A (en) | Agent for overcoming resistance to anti-cancer agent | |
| EP2900667B1 (en) | Means and method for treating solid tumours | |
| JP2009502770A5 (https=) | ||
| Sharma et al. | Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase iv inhibitors | |
| TW201100422A (en) | New crystalline form of pemirolast | |
| JP2016505017A (ja) | ２−（（１ｒ，４ｒ）−４−（４−（５−（ベンゾオキサゾール−２−イルアミノ）ピリジン−２−イル）フェニル）シクロヘキシル）酢酸のメグルミン塩形態、およびｄｇａｔ１阻害剤としてのそれらの使用 | |
| KR100280240B1 (ko) | 호산구 주화성 억제제 | |
| CN103435562B (zh) | 6-取代苯并二氮卓-2,4-二酮类化合物及其用途 | |
| CN117736193A (zh) | 一种氘代稠环化合物及其制备方法与用途 | |
| CN104327046B (zh) | 三氮唑‑n‑乙基四氢异喹啉类化合物及其制备方法和应用 | |
| CN110194769B (zh) | 一类hdac、cdk双靶点抑制剂及其制备方法与应用 | |
| JP6010614B2 (ja) | 血清尿酸を低下させるための［１，２，４］チアジアジン１，１−ジオキサイド化合物 | |
| CN113637019A (zh) | 一种选择性jak1抑制剂化合物及其制备方法和用途 |